Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19Review Article Published on 2023-06-192024-09-05 Journal: Genes & Diseases [Category] update2024, [키워드] gastrointestinal symptoms GI Tract gut microbiome inflammatory bowel diseases Intestinal barrier Long COVID metabolites tight junctions [DOI] 10.1016/j.gendis.2023.03.034 PMC 바로가기 [Article Type] Review Article
COVID-19 and Gut InjuryArticle Published on 2022-10-202022-11-15 Journal: Nutrients [Category] COVID19(2023년), SARS, 진단, [키워드] ACE2 acute respiratory syndrome angiotensin-converting enzyme 2 bind change children coronavirus COVID-19 COVID-19 infection COVID-19 patient COVID-19 patients death develop disorder females GI Tract Gut high risk host cell IBD increased risk Inflammatory Inflammatory bowel disease inflammatory cell inhibitor Injury mechanism microbiota monoclonal antibody pandemic Pathologies Patient Probiotics receptor recruitment reduce Respiratory system SARS-CoV-2 secreted cytokine severe COVID-19 susceptible Symptom the disease the patient therapeutic option Viral load [DOI] 10.3390/nu14204409 PMC 바로가기
Survival of Vaccine-Induced Human Milk SARS-CoV-2 IgG, IgA and SIgA Immunoglobulins across Simulated Human Infant Gastrointestinal Digestion인간 유아 위장 소화를 통한 백신 유도 모유 SARS-CoV-2 IgG, IgA 및 SIgA 면역글로불린의 생존Article Published on 2022-08-172022-09-12 Journal: Nutrients [Category] SARS, 진단, [키워드] adenovirus-based antibody Breastfeeding breastmilk COVID-19 COVID-19 pandemic Degradation digestion dose evaluated Evidence Gastrointestinal GI Tract help Human human milk IgA IgA antibody IgG Immunoglobulin immunoglobulins in vitro Inconclusive Infant information intestinal lactating milk mother mRNA-based vaccine natural infection passive immunity persistence Pfizer/BioNTech produced PROTECT protective role protocol recent reduced reduction SARS-CoV-2 SARS-CoV-2 IgG secretory IgA SIgA the SARS-CoV-2 virus the spike protein the vaccine transfer vaccination Vaccine women [DOI] 10.3390/nu14163368 PMC 바로가기 [Article Type] Article
COVID-19: gastrointestinal and hepatobiliary manifestationsReview article Published on 2022-07-012022-10-05 Journal: Human pathology [Category] COVID19(2023년), SARS, 변종, 치료제, [키워드] Colon complication of COVID-19 consequence COVID COVID-19 direct viral infection Gastrointestinal GI Tract hepatic injury Hepatitis liver manifestation Manifestations Mild pandemic pathologic pathology patients with COVID-19 Pulmonary infection reported SARS-CoV-2 Symptom viral infection [DOI] 10.1016/j.humpath.2022.07.006 [Article Type] Review article
Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infectionSARS-CoV-2 RNA의 위장 증상 및 배설물 배출은 장기간의 위장 감염을 시사합니다Article Published on 2022-06-102022-09-11 Journal: Med (New York, N.Y.) [Category] COVID19(2023년), SARS, 임상, 진단, 치료기술, [키워드] abdominal pain analyzed association confidence interval correlated COVID-19 COVID-19 diagnosis Diagnosis disease symptoms fecal fecal RNA fecal samples feces Gastrointestinal Gastrointestinal infection GI symptom GI symptoms GI Tract individual individuals with COVID-19 infect Infection intestinal lung Mild mild to moderate mild to moderate disease moderate disease nausea NIH Oropharyngeal participant Research Respiratory samples RNA SARS-CoV-2 SARS-CoV-2 RNA Stanford subject subset supported Symptom Symptoms viral replication Viral RNA Viral RNA shedding viral shedding vomiting [DOI] 10.1016/j.medj.2022.04.001 PMC 바로가기 [Article Type] Article
Immunoregulatory Intestinal Microbiota and COVID-19 in Patients with Type Two Diabetes: A Double-Edged Sword제2형 당뇨병 환자의 면역조절 장내 미생물총 및 COVID-19: 양날의 검Review Published on 2022-02-252022-09-12 Journal: Viruses [Category] MERS, 진단, [키워드] activate addition changes in Comorbidity Coronavirus disease 2019 Course COVID-19 COVID-19 disease COVID-19 patient functions GI Tract immune response immunoregulation IMPROVE induce intestinal intestinal bacteria intestinal microbiota intestine lung lung damage Lungs medication metformin microbiota modulate modulation organ pathology pro-inflammatory reduce Regulatory resulting SARS-CoV-2 severity subpopulations suppress Sword T cell T cell response T lymphocyte the disease the gut-lung axis treat Treatment Type type 2 diabete type 2 diabetes [DOI] 10.3390/v14030477 PMC 바로가기 [Article Type] Review
Disrupted Peyer’s Patch Microanatomy in COVID-19 Including Germinal Centre Atrophy Independent of Local Virus국부 바이러스와 무관한 생식 중심 위축을 포함한 COVID-19의 훼이어 패치 미세 해부학Immunology Published on 2022-02-172022-09-11 Journal: Frontiers in Immunology [Category] COVID19(2023년), MERS, SARS, 치료기술, [키워드] analysed Analysis architecture atrophy atrophy of lymphoid follicle B cell Cell cell interaction cellularity changes in Confirmed contribute coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patients Cytometry Depletion died Disrupted Disruption Gastrointestinal symptom gastrointestinal symptoms Germinal germinal centre Germinal centres GI Tract gut Sars-Cov2 infection ileal immune response immunohistochemistry Including independent independent of Infection Interaction intestinal lamina propria macrophages Local lymphoid tissues macrophages Microanatomy microbiota nuclear occurred patch Patient PCR Peyer’s patche Peyer’s patches Post-mortem reported severe COVID-19 severity T cell the disease tissue Viral virus with COVID-19 [DOI] 10.3389/fimmu.2022.838328 PMC 바로가기 [Article Type] Immunology
Safety and target engagement of an oral small-molecule sequestrant in adolescents with autism spectrum disorder: an open-label phase 1b/2a trial Research Published on 2022-02-142022-10-05 Journal: Nature Medicine [Category] 바이오마커, 임상, 진단, [키워드] activity affected Analysis Anxiety approach ASD autism spectrum bacterial metabolite baseline changes in circulation clinical trial defined disorder dose driven by endpoints enrolled evaluate exploratory Gastrointestinal GI symptom GI Tract Gut hallmark Health improvement individual irritability manifestation metabolite mice microbial Microbiome New Open-label Placebo-controlled trials plasma populations recent finding reduced Safe Safety Serious Adverse Event shown Significant reduction significantly social interaction Support Symptom Tolerability Treatment Trial Trial registration [DOI] 10.1038/s41591-022-01683-9 [Article Type] Research
COVID-19 and gut immunomodulation코로나19와 장 면역 조절Review Published on 2021-12-142022-09-12 Journal: World journal of gastroenterology [Category] SARS, 진단, [키워드] acute respiratory syndrome Adaptive immune response addition angiotensin-converting enzyme-2 antibodies association calprotectin changes in clinically Comorbidities coronavirus coronavirus disease COVID-19 COVID-19 patient COVID-19 patients Cytokines dependent on direct infection disease disease severity Dysbiosis epithelial cell expresse Gastrointestinal gastrointestinal symptoms GI symptom GI symptoms GI Tract Gut gut microbiota Health heterogeneous hypoxia immune immune activation immune response Immunity immunoglobulin A impairment in vitro in vivo infect infected individual Infection Innate innate immune response intestinal epithelium observation organ organoids outcome Pathogenesis Patient positive Pre-existing diseases Probiotic Proinflammatory cytokine protease Protein reported required respiratory problems respiratory symptom Respiratory system rhesus SARS-CoV-2 serine 2 severe COVID-19 patient severe respiratory illness severity Stool supported Symptom symptomatic patient the disease therapeutic interventions Therapeutics transmembrane Viral RNA virus [DOI] 10.3748/wjg.v27.i46.7925 PMC 바로가기 [Article Type] Review
Host Response to SARS-CoV2 and Emerging Variants in Pre-Existing Liver and Gastrointestinal Diseases기존 간 및 위장 질환의 SARS-CoV2 및 새로운 변이체에 대한 숙주 반응Review Published on 2021-10-252022-09-11 Journal: Frontiers in Cellular and Infection Microbiology [Category] MERS, SARS, 변종, 치료기술, [키워드] accumulation ACE2 receptor Alpha Alter Altered B.1.1.28.1 B.1.1.7 B.1.351 Beta binding Brazil changes in characteristic CLARITY cleavage condition coronavirus COVID-19 cytokine Cytokine storm Definitive determinant diabetes disease Diseases disorder disorders distribution drastic E484K emerging variants expression feature finding First wave Gastrointestinal gastrointestinal disease Generation GI Tract Host Host immune response host protease host protease TMPRSS2 host response hypertension Immune escape Immune status immunocompromised condition immunomodulation implicated incidence India indicate Infection Inflammation L452R lack less liver liver failure Liver injury manifestation Manifestations mechanism Mild Mortality Mutation N501Y novel Novel coronavirus obesity occur organs outcome outcomes P681R pandemic Patient predominant Protein binding radiologic receptor Receptor binding Replication reported required response risk factor RNA SARS-CoV2 selection pressure several variant several variants severe COVID-19 shown South Africa Spike protein Stool Symptoms systemic inflammation the disease the spike protein tissue expression TMPRSS2 Transmissibility Transmission underlying disease underlying diseases variant variants variants of concern Viral viral entry viral genome Viral proteins Viremia virulence virus virus clearance VoC [DOI] 10.3389/fcimb.2021.753249 PMC 바로가기 [Article Type] Review